SCHEMBL26627263

SCHEMBL26627263

CC(C)(C)c1cc(C(=O)O)c2cc(O)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.48
▸ ESR2 Q92731 3/20 0.48
▸ ALDH1A1 P00352 5/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ EPRS1 P07814 1/20 0.44
▸ HPGD P15428 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ DHODH Q02127 2/20 0.42
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA7 P43166 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ CA14 Q9ULX7 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ ALOX5 P09917 2/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ AKR1C3 P42330 1/20 0.40
▸ AKR1C2 P52895 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10018550 0.83 DHODH (0.60) ALDH1A1HSD17B10KDM4EHPGDPOLB
SCHEMBL25735933 0.83 RXFP1 (0.56) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL13343301 0.81 KDM4E (0.57) KDM4EPOLBDHODHAKR1C3AKR1C2
SCHEMBL5551250 0.79 ALDH1A1 (0.65) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL31553431 0.77 ESR1 (0.49) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL1897678 0.72 POLB (0.73) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL21247210 0.70 LMNA (0.62) ESR1ESR2ALDH1A1KDM4EEPRS1
SCHEMBL22718887 0.70 ALDH1A1 (0.64) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL29567655 0.70 ALDH1A1 (0.64) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL3015115 0.70 AKR1C3 (0.79) ESR1ESR2ALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263393-A1 FAP INHIBITORS SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) 2025-08-21 — — US disclosed
EP-4511367-A1 FAP INHIBITORS Shanghai Sinotau Biotech. Co., Ltd (CN) 2025-02-26 — — EP disclosed
WO-2024022332-A1 FAP INHIBITORS SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) 2024-02-01 — — WO disclosed
WO-2023202655-A1 FAP INHIBITORS SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) 2023-10-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263393-A1 FAP INHIBITORS FAP, APC, FIBP ESR1 4708/4885ESR2 4188/4885ALDH1A1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback